Accuray Gross Profit 2011-2025 | ARAY
Accuray gross profit from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Accuray Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $147 |
| 2024 | $143 |
| 2023 | $154 |
| 2022 | $160 |
| 2021 | $160 |
| 2020 | $150 |
| 2019 | $163 |
| 2018 | $162 |
| 2017 | $141 |
| 2016 | $159 |
| 2015 | $145 |
| 2014 | $143 |
| 2013 | $98 |
| 2012 | $137 |
| 2011 | $107 |
|
Accuray Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-06-30 | $39 |
| 2025-03-31 | $32 |
| 2024-12-31 | $42 |
| 2024-09-30 | $34 |
| 2024-06-30 | $38 |
| 2024-03-31 | $29 |
| 2023-12-31 | $36 |
| 2023-09-30 | $39 |
| 2023-06-30 | $38 |
| 2023-03-31 | $39 |
| 2022-12-31 | $43 |
| 2022-09-30 | $35 |
| 2022-06-30 | $43 |
| 2022-03-31 | $35 |
| 2021-12-31 | $43 |
| 2021-09-30 | $40 |
| 2021-06-30 | $44 |
| 2021-03-31 | $40 |
| 2020-12-31 | $41 |
| 2020-09-30 | $35 |
| 2020-06-30 | $40 |
| 2020-03-31 | $39 |
| 2019-12-31 | $38 |
| 2019-09-30 | $33 |
| 2019-06-30 | $46 |
| 2019-03-31 | $40 |
| 2018-12-31 | $38 |
| 2018-09-30 | $38 |
| 2018-06-30 | $48 |
| 2018-03-31 | $36 |
| 2017-12-31 | $39 |
| 2017-09-30 | $38 |
| 2017-06-30 | $43 |
| 2017-03-31 | $35 |
| 2016-12-31 | $31 |
| 2016-09-30 | $31 |
| 2016-06-30 | $37 |
| 2016-03-31 | $45 |
| 2015-12-31 | $43 |
| 2015-09-30 | $34 |
| 2015-06-30 | $40 |
| 2015-03-31 | $39 |
| 2014-12-31 | $38 |
| 2014-09-30 | $28 |
| 2014-06-30 | $38 |
| 2014-03-31 | $40 |
| 2013-12-31 | $38 |
| 2013-09-30 | $26 |
| 2013-06-30 | $27 |
| 2013-03-31 | $20 |
| 2012-12-31 | $27 |
| 2012-09-30 | $24 |
| 2012-06-30 | $36 |
| 2012-03-31 | $36 |
| 2011-12-31 | $40 |
| 2011-09-30 | $24 |
| 2011-06-30 | $32 |
| 2011-03-31 | $27 |
| 2010-12-31 | $29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.163B | $0.459B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.267B | 25.34 |
| Intuitive Surgical (ISRG) | United States | $196.642B | 76.93 |
| IDEXX Laboratories (IDXX) | United States | $57.510B | 57.11 |
| Edwards Lifesciences (EW) | United States | $48.635B | 32.23 |
| Alcon (ALC) | Switzerland | $36.668B | 24.62 |
| IQVIA Holdings (IQV) | United States | $35.783B | 19.95 |
| Mettler-Toledo (MTD) | United States | $29.657B | 35.20 |
| STERIS (STE) | Ireland | $23.951B | 24.64 |
| DexCom (DXCM) | United States | $23.120B | 31.87 |
| Waters (WAT) | United States | $22.145B | 29.29 |
| Hologic (HOLX) | United States | $16.510B | 17.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.063B | 0.00 |
| Penumbra (PEN) | United States | $8.796B | 62.13 |
| Globus Medical (GMED) | United States | $8.307B | 19.16 |
| Masimo (MASI) | United States | $7.635B | 24.47 |
| Sysmex ADR (SSMXY) | Japan | $6.484B | 20.60 |
| Teleflex (TFX) | United States | $5.513B | 8.90 |
| Glaukos (GKOS) | United States | $4.845B | 0.00 |
| TransMedics (TMDX) | United States | $4.253B | 50.39 |
| Veracyte (VCYT) | United States | $3.622B | 41.48 |
| Alphatec Holdings (ATEC) | United States | $2.929B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.774B | 14.99 |
| Integer Holdings (ITGR) | United States | $2.388B | 11.21 |
| Artivion (AORT) | United States | $2.195B | 110.74 |
| Nihon Kohden (NHNKY) | Japan | $1.980B | 23.63 |
| PROCEPT BioRobotics (PRCT) | United States | $1.759B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.736B | 16.82 |
| Beta Bionics (BBNX) | United States | $1.167B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.095B | 0.00 |
| IRadimed (IRMD) | United States | $1.081B | 51.49 |
| AxoGen (AXGN) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.888B | 4.81 |
| SiBone (SIBN) | United States | $0.663B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.541B | 31.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.495B | 9.87 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.483B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.435B | 3.42 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 10.38 |
| Treace Medical Concepts (TMCI) | United States | $0.395B | 0.00 |
| RxSight (RXST) | United States | $0.341B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.336B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.307B | 51.06 |
| Spectral Diagnostics (EDTXF) | Canada | $0.292B | 0.00 |
| 908 Devices (MASS) | United States | $0.290B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.263B | 0.00 |
| CVRx (CVRX) | United States | $0.256B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Neuronetics (STIM) | United States | $0.188B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Hyperfine (HYPR) | United States | $0.089B | 0.00 |
| InspireMD (NSPR) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.080B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.042B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |